Author

S. Zelenay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. G. van der Veen· 1 shared A. Nicolas· 1 shared A. Vincent-Salomon· 1 shared B. Buttard· 1 shared C. Bromley· 1 shared C. P. Bromley· 1 shared C. Reis e Sousa· 1 shared C. Sedlik· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. G. van der Veen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

RNA sensing via LGP2 is essential for the induction of a type I IFN response in ADAR1 deficiency

J. E. Stok, T. Oosenbrug, L. R. ter Haar, D. Gravekamp, C. P. Bromley, S. Zelenay, C. Reis e Sousa, A. G. van der Veen

This study shows that LGP2 is essential for type I IFN induction in ADAR1-deficient cells, with implications for AGS and cancer therapy.

bioRxiv · Oct 27, 2021Immunology

Tissue-resident FOLR2+ macrophages associate with tumor-infiltrating CD8+ T cells and with increased survival of breast cancer patients.

R. N. Ramos, Y. Missolo-Koussou, Y. Gerber-Ferder, C. Bromley, M. Bugatti, N. G. Nunez, J. Boari Tosello, W. Richer, J. Denizeau, C. Sedlik, P. Caudana, F. Kotsias, L. L. Niborski, S. Viel, M. Bohec, , J. Helft

The paper identifies FOLR2+ macrophages in breast cancer that correlate with improved patient survival and co-localize with CD8+ T cells across multiple cancers.

bioRxiv · Apr 12, 2021 · PreprintImmunology